MannKind Corporation (NASDAQ:MNKD) shares are on a close to 43% climb following the biotech firm’s announcement of an agreement reached with Sanofi on …
By Dana Lyons A key gauge of biotechnology stocks is testing major trendline support presently – can it hold yet again? When this …
MannKind Corporation (NASDAQ:MNKD) announced that the United States District Court for the Central District of California has dismissed the class action that was …
Piper Jaffray remains skeptical about relaunch strategies and their impact on Afrezza’s prescription numbers.
MannKind Corporation (NASDAQ:MNKD) just reported second-quarter results. Recently, MNKD has begun to distribute to major wholesalers its pipeline drug Afrezza, a fast-acting inhalant …
MannKind Corporation (NASDAQ:MNKD) reported financial results for the second quarter and the six months ended June 30, 2016. For the second quarter ended June …
LinkedIn Corp (NYSE:LNKD) is up a whopping 48% after Microsoft agreed to buy the company for $26.2 billion in cash.
MannKind Corporation (NASDAQ:MNKD) announced results of two late-breaking posters and four additional analyses of Afrezza® (insulin human) Inhalation Powder, including three posters demonstrating a …
MannKind Corporation (NASDAQ:MNKD) announced that it has entered into a collaboration agreement with JDRF (formerly known as Juvenile Diabetes Research Foundation), the leading global …
SolarCity Corp (NASDAQ:SCTY) is falling 20% in pre-market trading after the company reported Q1:16 earnings yesterday after market close. The company posted revenues …
